Company intelligence / Profile preview

Arctos NorthStar Acquisition

Dallas, Texas, United Statessec.gov ↗

Ownership: Public · ANAC
Development stage: Other

Overview

Arctos NorthStar Acquisition was a blank check company formed to pursue mergers or acquisitions, primarily targeting the sports, media, and entertainment sectors. It did not operate in the life sciences/biotech/pharma/healthcare space and had no clinical pipeline or therapeutic focus. The company was liquidated in early 2023 after failing to complete a business combination within its designated timeframe[5][10].

Industry: Investors

Financials

Market cap: $419.4M
Total revenue: $0
Enterprise value: $419.2M

Beyond the preview

Go deeper on Arctos NorthStar Acquisition.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arctos NorthStar Acquisition.

Explore the full profile